You Position: Home > Paper

Construction of a new DNA vaccine based on truncated BAP31 and study on its anti-tumor effects

( views:31, downloads:0 )
Author:
No author available
Journal Title:
JOURNAL OF THE FOURTH MILITARY MEDICAL UNIVERSITY
Issue:
14
DOI:
10.3321/j.issn:1000-2790.2009.14.002
Key Word:
BAP31分子;LAMP分子;疫苗,DNA;酶联免疫斑点试验;BAP31;LAMP;vaccines,DNA;ELISPOT

Abstract: AIM: To develop an anti-tumor DNA vaccine encoding a truncated protein of routine BAP31 (△BAF31) to en-hance endogenous antigen trafficking to the MHC-Ⅱ compartment of antigen-presenting cells by LAMP and to study its efficacy to induce cellular and humoral immunity. METHODS: The DNA vaccine was identified by restriction enzyme analysis, sequencing and protein expression. The frequency of cells producing IFN-γ or IL-4 in splenocytes immunized mice was measured by ELISPOT. Specific antibodies for △BAP31 were determined by indirect ELISA and cytotoxicity of specific CTL was measured by LDH releasing assay. RESULTS : ELISPOT showed that the number of IFN-γ and IL-4-producing cells in LAMP group was significantly higher than that in control groups. The level of △BAP31 specific antibodies and CTL the cytotoxicity in LAMP group were markedly higher than those in control groups. CONCLUSION: LAMP enhances cellular and humoral response through greater antigen-specific activation of both CD4+ T cells and CD8+ T cells.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn